Results 41 to 50 of about 9,828 (193)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy

open access: yesBiomedicines, 2023
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable progressive myocardial disorder that predisposes patients to ventricular arrhythmias and sudden cardiac death.
Sean P. Gaine, Hugh Calkins
doaj   +1 more source

Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Clinical Outcomes of Pulmonary Vein Isolation Alone Versus Additional Lesion Sets in Paroxysmal Atrial Fibrillation ABSTRACT Background Pulmonary vein isolation (PVI) is the standard ablation strategy for paroxysmal atrial fibrillation (PAF). Despite guideline recommendations favoring PVI alone in PAF, some operators routinely perform extra pulmonary ...
Michel Abou Khalil   +17 more
wiley   +1 more source

Frequent Premature Ventricular Complexes and Catheter Ablation for Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Among 421 patients undergoing ablation of atrial fibrillation, frequent premature ventricular complexes (PVCs) > 1% were present in a significant proportion of patients at baseline. The PVC burden did not increase significantly in the post‐AF ablation period and was not associated with a higher rate of recurrent AF.
Abdulmohsen Alshakhs   +9 more
wiley   +1 more source

Zero‐Fluoroscopy Ablation Methods for Atrial Fibrillation: A Systematic Review and Meta‐Analysis

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Central illustration. Schematic comparison of conventional fluoroscopy guided ablation (left) and zero fluoroscopy ablation (right), enabled by electroanatomical mapping and intracardiac echocardiography for catheter navigation without X ray. The study selection process is summarized (133 records identified; 12 studies included, total n = 1998 ...
Marwan Shawki   +5 more
wiley   +1 more source

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients

open access: yesStem Cells International, 2018
Mutations in the cardiac ryanodine receptor (RYR2) are the leading cause for catecholaminergic polymorphic ventricular tachycardia (CPVT). In this study, we evaluated antiarrhythmic efficacy of carvedilol and flecainide in CPVT patient-specific induced ...
R. P. Pölönen   +3 more
doaj   +1 more source

A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide

open access: yesIndian Heart Journal, 2020
Background: Achievement of sinus rhythm (SR) is an important goal in rheumatic atrial fibrillation (AF). Studies in rheumatic AF have often used amiodarone for rhythm control.
Anindya Ghosh   +7 more
doaj   +1 more source

Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. [PDF]

open access: yesPLoS ONE, 2010
BACKGROUND: Antiarrhythmic action of flecainide is based on sodium channel blockade. Beta(1)-adrenoceptor (beta(1)AR) activation induces sodium channel inhibition, too.
Amir M Nia   +9 more
doaj   +1 more source

Lifestyle modification in atrial fibrillation: Mechanisms, phenotypes and ablation outcomes

open access: yesExperimental Physiology, EarlyView.
Abstract Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia and is associated with significant morbidity, mortality and healthcare utilization. Catheter ablation is increasingly used as a rhythm‐control intervention for patients with symptomatic paroxysmal and persistent AF, yet recurrence rates remain suboptimal.
Konstantinos Grigoriou   +11 more
wiley   +1 more source

Mechanistic insights into sex differences in atrial electrophysiology and arrhythmia vulnerability through sex‐specific computational models

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Sex‐specific models of the human atrial myocyte in normal sinus rhythm (nSR) and chronic atrial fibrillation (cAF) revealed increased alternans susceptibility in cAF males and DADs in females, driven primarily by ICaL and ryanodine receptor remodelling.
Nathaniel T. Herrera   +6 more
wiley   +1 more source

Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Most genes involved in inherited primary arrhythmia syndromes (IPAS) are conserved in Caenorhabditis elegans, where genetic manipulation enables functional characterization of variants, identification of regulatory proteins, and in vivo drug testing.
Antoine Delinière   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy